Leidos

LDOS · NYSE · Industrials · Financials, fiscal 2016 to 2025

LDOS · Last close · October 26, 2026

$139.86

Leidos' revenue rose 3.1% to $17.2 billion in fiscal 2025. Its operating margin was 12.3%, up from 11.0% a year earlier. Free cash flow was $1.6 billion, up 26.4%. It paid out $611 million in dividends and buybacks, 38% of free cash flow. The diluted share count fell 4.4%.

Leidos Holdings, Inc. Latest fiscal year ended January 2, 2026 10-K filed February 17, 2026 · 0001336920-26-000030 Updated October 9, 2026

Revenue

$17.2B

3.1%

Operating margin

12.3%

1.3 pts

Net income

$1.4B

15.5%

Free cash flow

$1.6B

26.4%

Return on capital

19.2%

2.4 pts

Market cap

$17.6B

Oct 26 close

P/E

13.1x

On $10.71 EPS, 4 qtrs

Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.

What Leidos does

Leidos provides science, engineering and technology services and solutions, mostly to the U.S. government. Its customers include the Department of War, the intelligence community, the Department of Homeland Security, the Federal Aviation Administration and the Department of Veterans Affairs, plus state and foreign governments and some commercial businesses. It is based in Reston, Virginia, and has about 47,000 employees.

It reports four segments. In fiscal 2025, National Security & Digital was 44% of revenue, Health & Civil 30%, Commercial & International 13% and Defense Systems 13%. In that year Leidos got 87% of its revenue from U.S. government contracts, as a prime contractor or as a subcontractor to others.

It says it is focused on five areas for growth: space and maritime, energy infrastructure, digital modernization and cyber, mission software, and managed health services. Leidos describes its competition as intense and says winning contracts is a competitive process.

Its biggest risks, as it describes them

Depending on government agencies as its main customers, so harm to those relationships would hurt future revenue.
Cuts or delays in the U.S. government budget and contract awards.
The government can end, change or cut back contracts at any time, and rivals can protest awards.
Intense competition for contracts.
Audits, investigations and strict procurement rules, which can lead to penalties.

From Leidos's annual report on Form 10-K, filed February 17, 2026, in our words; the 10-K has the full description and every risk factor. Updated with each new 10-K.

Charts show fiscal years, from the 10-K filings.

Revenue and margins

Revenue

US$ billions, fiscal years

Margins

Percent of revenue

GrossOperatingNetFree cash flow

Net income and earnings per share

From fiscal 2016 to 2025, earnings per share grew 18.9% a year and net income 21.9% a year, as new shares raised the share count by 25% and diluted each share's earnings.

Net income

US$ billions, fiscal years; loss years in red.

Diluted earnings per share

US$ per share, fiscal years, restated for any stock splits; loss years in red.

Returns on capital

Return on capital and on equity

Percent. Return on capital is after-tax operating income over the money invested in the business (debt plus equity, minus cash); return on equity is net income over shareholders' equity. Both use the average of opening and closing balances.

Return on capitalReturn on equity

Cash flow

Free cash flow

US$ billions. Cash from operations minus capital expenditure; negative years in red.

Payouts and share count

Dividends and buybacks

US$ billions, cash paid in each fiscal year

DividendsShare buybacks

Diluted share count

Weighted-average diluted shares, millions

Valuation

Two ways to value Leidos yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.

Discounted cash flow (DCF)

A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Leidos' 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.

Value per share on three example scenarios, from Leidos' fiscal 2025 free cash flow of $1.6B, net cash of −$3.5B at January 2, 2026 and 130 million diluted shares, from its filings. The scenarios are fitted to Leidos: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, 6.1% a year; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 9% for a business of moderate risk (Diversified Support Services); the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.

From the filings

Starting free cash flow, US$ millions

Cash from operations minus capital spending in fiscal 2025.

Net cash, US$ millions

Cash and short-term investments minus debt and finance leases at January 2, 2026. Negative means net debt.

Diluted shares, millions

Weighted-average diluted shares in fiscal 2025.

Your assumptions

Start from

Fitted to Leidos's own revenue growth, as above. Cautious: growth of 3% then 2.5% a year, 2% after year 10, a 10% discount rate. Base: growth of 6% then 4% a year, 2.5% after year 10, a 9% discount rate. Optimistic: growth of 9% then 6% a year, 3% after year 10, a 8% discount rate.

Free cash flow growth, years 1 to 5 (% a year)

Free cash flow growth, years 6 to 10 (% a year)

Growth after year 10 (% a year)Long-run growth forever after year 10. Usually close to inflation, and always below the discount rate.

Discount rate (% a year)The yearly return an investor wants for the risk. A higher rate gives a lower value.

Value per share on these assumptions

—

Last close, October 26, 2026: $139.86
Value on these assumptions, against the last close: —

Cash flows in years 1 to 10, valued today: —
Everything after year 10, valued today: —
Plus net cash: —
Share of value from after year 10: —

Projected free cash flow

US$ billions. Each column is one year's projected free cash flow, split into what it is worth today and the part removed by discounting.

Value todayRemoved by discounting

How the value changes with two assumptions

Value per share in US$, with the growth rates above. The highlighted cell matches the current assumptions.

How the model works. Free cash flow grows at the first rate for five years and the second rate for five more, and each year is discounted at the discount rate. Everything after year 10 is valued as year-10 cash flow × (1 + growth after year 10) ÷ (discount rate − growth after year 10), discounted back ten years. Net cash is added and the total is divided by diluted shares. The result depends entirely on the assumptions. It is not a forecast, a price target or a recommendation. The last close is the consolidated US closing price, from Databento.

Price-to-earnings (P/E) method

Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.

Value per share on three example scenarios, from Leidos' earnings per share of $10.71 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 22.3×, the middle of Leidos' own P/E today, its peers' median and its sector's median (its peers' median) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 10%, 9% and 8%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.

Earnings per share, US$

Diluted earnings per share over the four quarters to July 3, 2026, from the 10-Qs and 10-K.

P/E multiple

P/E today is the last close divided by the latest earnings per share, the four quarters' where available. Peers: Cintas, CACI International, KBR, Science Applications Intl.

Earnings growth in the years ahead (% a year) Starts at Leidos' revenue growth over the last 3 years, 6.1% a year, as the base scenario does.

Earnings per share in the years ahead, US$

Year 1Year 2Year 3Year 4Year 5

Type your own estimate for any year; the years after it carry on at the growth rate.

Apply the multiple to earnings

A multiple on a future year's earnings gives the price then, brought back to today at the discount rate below.

Discount rate (% a year) The yearly return an investor wants for the risk, as in the cash flow model.

Value per share today at this multiple

—

Last close, October 26, 2026: $139.86
Value at this multiple, against the last close: —
Leidos' P/E at the last close: 13.1×

Company	Last close	Earnings per share	P/E today
CintasCTAS	$225.93	$5.07	44.6×
CACI InternationalCACI	$665.00	$24.36	27.3×
Science Applications IntlSAIC	$148.51	$8.56	17.3×
LeidosLDOS	$139.86	$10.71	13.1×
KBRKBR	$40.02	$3.33	12.0×

How the P/E method works. Value per share is earnings per share times the multiple. On a future year's earnings, that gives the price in that year, which is brought back to today at the discount rate: price ÷ (1 + discount rate) for each year ahead. It is quick and easy to compare across companies, but it ignores debt and cash, and earnings can swing with one-off gains and charges, so a multiple says most about steady, profitable businesses. Like the cash flow model, the result depends entirely on the assumptions you choose. It is not a forecast, a price target or a recommendation.

Balance sheet

Fiscal year end	FY21	FY22	FY23	FY24	FY25
Cash and short-term investments	727	516	641	849	1,108
Debt incl. finance leases	5,179	5,592	4,700	4,670	4,648
Net debt (negative means net cash)	4,452	5,076	4,059	3,821	3,540
Net debt to EBITDA	3.0x	3.6x	4.3x	1.8x	1.5x
Debt to equity	1.2x	1.3x	1.1x	1.1x	0.9x
Interest coverage	6.2x	5.6x	3.0x	8.1x	9.6x
Current ratio	1.1x	0.9x	1.3x	1.2x	1.7x
Quick ratio	1.0x	0.8x	1.2x	1.1x	1.6x

US$ millions unless stated, at each fiscal year end. Net debt to EBITDA is debt minus cash, divided by operating income before depreciation and amortization: roughly how many years of those earnings the net debt equals. Debt to equity is debt as a multiple of shareholders' equity. Interest coverage is operating income divided by interest expense. The current ratio is current assets over current liabilities; the quick ratio leaves out inventory.

Insider trades

Over the 12 months between October 27, 2025 and October 26, 2026, no insider bought Leidos shares on the open market, and 3 insiders sold $3.2 million, $1.4 million of it under trading plans set up in advance.

Date	Insider	Trade	Shares	Price	Value	Filing
Sep 1, 2026	Gary Stephen MayDirector	Sold	1,000	$140.85	$140,850	Form 4
Aug 11, 2026	Noel B GeerDirector	Sold	10,000	$140.66	$1.4 million	Form 4
May 7, 2026	Gary Stephen MayDirector	Sold	1,484	$132.75	$197,001	Form 4
Apr 7, 2026	Elizabeth A PorterSector President	Sold plan	2,000	$158.77	$317,549	Form 4
Jan 20, 2026	Elizabeth A PorterSector President	Sold plan	3,000	$192.21	$576,630	Form 4
Dec 19, 2025	Elizabeth A PorterSector President	Sold plan	3,000	$181.04	$543,130	Form 4

Open-market purchases and sales by officers, directors and 10% owners, from their Form 4 filings with the SEC: one row per person, day and filing, at the day's average price. Grants, option exercises and shares withheld for tax aren't counted. Insiders buy and sell for many reasons, such as taxes, spreading their savings or a plan set up months earlier, so a trade on its own says little about where a company is heading. For information only, not investment advice. Insider trades at all companies

Piotroski F-score

The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.

Test	FY23	FY24	FY25
Net income is positive	Pass	Pass	Pass
Cash from operations is positive	Pass	Pass	Pass
Return on assets rose	Fail	Pass	Pass
Cash from operations exceeds net income	Pass	Pass	Pass
Debt fell relative to assets	Pass	Pass	Pass
Current ratio rose	Pass	Fail	Pass
Share count didn't rise	Pass	Pass	Pass
Gross margin rose	Pass	Pass	Pass
Revenue rose relative to assets	Pass	Pass	Pass
F-score	8 of 9	8 of 9	9 of 9
Accruals ratio	−7.7%	−1.4%	−2.3%

The accruals ratio is net income minus cash from operations, over average total assets.

Compare

Put Leidos side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.

Similar companies

Company	Year	Revenue growth	Operating margin	Free cash flow margin	Return on capital	Net debt to EBITDA	F-score	Compare
Leidos	FY25	3.1%	12.3%	9.5%	19.2%	1.5x	9
Cintas	FY26	8.9%	23.1%	16.7%	31.7%	0.4x	8	Compare
CACI International	FY26	10.9%	9.6%	8.2%	8.8%	4.7x	5	Compare
KBR	FY25	1.0%	10.0%	6.6%	15.8%	2.2x	7	Compare
Science Applications Intl	FY26	−2.9%	7.2%	8.0%	12.8%	4.2x	7	Compare

Each company's latest fiscal year. Fiscal years end in different months, so the periods don't line up exactly. Free cash flow margin is free cash flow as a share of revenue. Net debt to EBITDA is explained under the balance sheet, and the F-score above.

10 years of figures

Fiscal year	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Income statement
Revenue	7,043	10,170	10,194	11,094	12,297	13,737	14,396	15,438	16,662	17,174
Revenue growth	49.5%	44.4%	0.2%	8.8%	10.8%	11.7%	4.8%	7.2%	7.9%	3.1%
Gross profit	940	1,432	1,504	1,548	1,737	2,014	2,084	2,244	2,798	3,099
Research and development	44	42	46	49	73	109	116	128	150	187
Operating income	417	559	749	912	998	1,152	1,088	621	1,827	2,109
Net income	244	366	581	667	628	753	685	199	1,254	1,448
Diluted EPS (US$)	2.35	2.38	3.80	4.60	4.36	5.27	4.96	1.44	9.22	11.14
Diluted shares (millions)	104	154	153	145	144	143	138	138	136	130
Cash flow
Cash from operations	449	526	768	992	1,334	1,033	992	1,187	1,435	1,750
Capital expenditure	29	81	73	121	183	104	129	207	149	125
Free cash flow	420	445	695	871	1,151	929	863	980	1,286	1,625
Dividends paid	993	0	0	198	196	199	199	201	208	211
Share buybacks	0	0	167	25	67	237	0	225	850	400
Acquisitions	25	0	81	94	2,655	622	192	6	0	293
Stock-based compensation	35	43	44	52	62	67	73	77	85	95
Balance sheet at fiscal year end
Cash and short-term investments	376	390	327	668	524	727	516	641	849	1,108
Debt incl. finance leases	3,287	3,111	3,124	2,986	4,744	5,179	5,592	4,700	4,670	4,648
Total assets	9,132	8,990	8,770	9,367	12,511	13,261	13,071	12,695	13,010	13,493
Total liabilities	5,985	5,607	5,459	5,950	8,640	8,917	8,718	8,437	8,550	8,531
Shareholders' equity	3,135	3,370	3,308	3,413	3,862	4,291	4,299	4,201	4,412	4,916
Margins and ratios
Gross margin	13.3%	14.1%	14.8%	13.9%	14.1%	14.7%	14.5%	14.5%	16.8%	18.0%
Operating margin	5.9%	5.5%	7.3%	8.2%	8.1%	8.4%	7.6%	4.0%	11.0%	12.3%
Net margin	3.5%	3.6%	5.7%	6.0%	5.1%	5.5%	4.8%	1.3%	7.5%	8.4%
Free cash flow margin	6.0%	4.4%	6.8%	7.8%	9.4%	6.8%	6.0%	6.3%	7.7%	9.5%
Return on capital	8.5%	8.5%	11.7%	11.9%	11.6%	10.7%	9.3%	3.6%	16.8%	19.2%
Return on equity	11.6%	11.2%	17.4%	19.9%	17.3%	18.5%	15.9%	4.7%	29.1%	31.1%
Return on assets	3.9%	4.0%	6.5%	7.4%	5.7%	5.8%	5.2%	1.5%	9.8%	10.9%
Net debt to EBITDA	5.4x	3.0x	2.8x	2.0x	3.3x	3.0x	3.6x	4.3x	1.8x	1.5x

US$ millions unless stated. Where a later 10-K restated a year, the latest filed figure is shown. Download all figures (CSV, US$ millions)

Source: Leidos' Form 10-K filings, from SEC EDGAR. For information only, not investment advice. The Filing Desk is not affiliated with Leidos.